| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I/II Trial of Trastuzumab and Gefitinib in Patients with Metastatic Breast Cancer That Overexpresses HER2/neu (ErbB-2)
|
Moulder, Stacy L.
|
|
2003
|
4 |
2 |
p. 142-145
4 p.
|
artikel
|
| 2 |
A Phase I Study of Capecitabine in Combination with Vinorelbine in Advanced Breast Cancer
|
Lorusso, Vito
|
|
2003
|
4 |
2 |
p. 138-141
4 p.
|
artikel
|
| 3 |
Biologically Targeted Therapy: As Good as Advertised?
|
Tripathy, Debu
|
|
2003
|
4 |
2 |
p. 89-
1 p.
|
artikel
|
| 4 |
Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group
|
Fountzilas, George
|
|
2003
|
4 |
2 |
p. 120-125
6 p.
|
artikel
|
| 5 |
2003 Highlights from: 39th Annual Meeting of the American Society of Clinical Oncology; Chicago, Illinois May 31 to June 3, 2003
|
D'Orazio, Amy I.
|
|
2003
|
4 |
2 |
p. 92-97
6 p.
|
artikel
|
| 6 |
Increased Rate of Brain Metastasis with Trastuzumab Therapy Not Associated with Impaired Survival
|
Lower, Elyse E.
|
|
2003
|
4 |
2 |
p. 114-119
6 p.
|
artikel
|
| 7 |
Integration of Systemic Therapy and Radiation Therapy for Patients with Early-Stage Breast Cancer Treated with Conservative Surgery
|
Recht, Abram
|
|
2003
|
4 |
2 |
p. 104-113
10 p.
|
artikel
|
| 8 |
Mammalian Target of Rapamycin: A New Molecular Target for Breast Cancer
|
Mita, Monica M.
|
|
2003
|
4 |
2 |
p. 126-137
12 p.
|
artikel
|
| 9 |
Recent Data with Gemcitabine-Based Chemotherapy Combinations in Metastatic Breast Cancer
|
DeGrendele, Heather
|
|
2003
|
4 |
2 |
p. 98-100
3 p.
|
artikel
|
| 10 |
What Is the Role of Ovarian Function Suppression in the Treatment of Premenopausal Breast Cancer Patients?
|
D'Orazio, Amy
|
|
2003
|
4 |
2 |
p. 101-103
3 p.
|
artikel
|
Tijdschrift beschrijving